PDA Webinar: Advancing Advanced Therapy Medicinal Products in a Dynamic Regulatory Environment

Online
Ask a Question

Moderator: Michael N. Blackton, MBA, Vice President, Quality, Adaptimmune LLC 

Join us for an in-depth exploration of the current state of development and regulatory thought for the advancement of advanced therapy medicinal products globally.

This webinar will examine cell and gene therapy product development and innovation in a way that helps foster understanding of the evolving landscape of global regulatory requirements in order to advance these therapies through approval and beyond.

Following two presentations by leaders in the field, get your questions answered during a live 30-minute Q&A session with the speakers.

This webinar is presented as part of the 2020 PDA Advanced Therapy Medicinal Products Month.

Contact

Program Inquiries
Training Course Inquiries
Registration Customer Care

Standard Pricing

Standard Member Price

$200

GovernmentMember Only

$200

Health AuthorityMember Only

$200

AcademicMember Only

$200

Non-Member

$200

See Qualifying Criteria for Member Types.

Day 1

11:00 a.m. – 11:30 a.m.
Engineered T Cell Therapies: Development, Global Regulatory Approvals, and Future Trends
Bruce L. Levine, PhD, CCI Deputy Director, Technology Innovation and Assessment,University of Pennsylvania

11:30 a.m. – 12:00 p.m.
Dennis Williams, PharmD, Senior Vice President, Late Stage Development, Adaptimmune LLC

12:00 p.m. – 12:30 p.m.
Q&A with Speakers

PLEASE READ  PDA is not affiliated or contracted with any outside hotel contracting company. If someone other than PDA or the PDA chosen hotel contacts you suggesting that they represent any PDA event, they do not. It is PDA's recommendation that you book your hotel directly through the official PDA chosen hotel that is listed on our web site.


Online, ,